Evidence map›Paper›PMID 37273644›Full record

ArticleACS omega2023

Imidazopyridine Amides: Synthesis,

Rana Abdelaziz, Justin M Di Trani, Henok Sahile, Lea Mann, Adrian Richter, Zhongle Liu, Stephanie A Bueler, Leah E Cowen, John L Rubinstein, Peter Imming

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Rana AbdelazizInstitut Für Pharmazie, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale) 06120, Germany.
Justin M Di TraniMolecular Medicine Program, The Hospital for Sick Children, Toronto M5G 0A4, Canada.
Henok SahileDepartments of Medicine and Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver V6T 1Z3, Canada.
Lea MannInstitut Für Pharmazie, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale) 06120, Germany.
Adrian RichterInstitut Für Pharmazie, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale) 06120, Germany.ORCID https://orcid.org/0000-0002-0062-7896
Zhongle LiuDepartment of Molecular Genetics, The University of Toronto, Toronto M5G 0A4, Canada.
Stephanie A BuelerMolecular Medicine Program, The Hospital for Sick Children, Toronto M5G 0A4, Canada.
Leah E CowenDepartment of Molecular Genetics, The University of Toronto, Toronto M5G 0A4, Canada.ORCID https://orcid.org/0000-0001-5797-0110
John L RubinsteinMolecular Medicine Program, The Hospital for Sick Children, Toronto M5G 0A4, Canada.ORCID https://orcid.org/0000-0003-0566-2209
Peter ImmingInstitut Für Pharmazie, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale) 06120, Germany.ORCID https://orcid.org/0000-0003-2178-3887
Martin Luther University Halle-Wittenberg · DEUniversity of Toronto · CAHospital for Sick Children · CAUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Q203 (telacebec) is an imidazopyridine amide (IPA) targeting the respiratory CIII

Identifiers

PMID37273644
PMCPMC10233671
OpenAlexW4377104678

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.